Waters Corporation (WAT)
WATNYSEBiotechnology: Laboratory Analytical Instruments
$477.24
+19.64 (+4.29%) today
At the close, Nov 9, 4:02 PM ET. After hours $485.52 +1.81%
- Market cap
- $46.85bn
- P/E
- 33.2
- EPS, last 4 quarters
- $14.38
- Dividend yield
- –
- Day range
- $457.57 to $480.32
- 52-week range
- $282.77 to $482.28
- Average volume
- 549.6k
- Previous close
- $457.60
Analysts
16 coveringBuy11 buy, 5 hold, 0 sell
Targets a year out average $495.00, +3.7% from here
Earnings
next estimate $4.63Next report
Dec 2025
+0.7%
Mar 2026
+16.9%
Jun 2026
+1.3%
Sep 2026
+2.8%
estimate reported, and the surprise
Financials
| Quarter | Mar 2025 | Sep 2025 | Dec 2025 | Apr 2026 |
|---|---|---|---|---|
| Revenue | $662.00m | $2.23bn | $932.36m | $1.27bn |
| Gross profit | $385.00m | $1.90bn | $569.50m | $588.00m |
| Operating income | $152.00m | $192.07m | $270.52m | -$47.00m |
| Net income | $121.00m | $149.41m | $225.21m | -$72.00m |
Last four quarters: revenue $5.09bn, margin 8.3%, free cash flow $479.81m
News
8 latest- Waters Expands Proteomics Reach With MOBILion Systems AcquisitionZacks · 6 hours ago
- Waters Q3 Earnings Call HighlightsMarketBeat · 5 days ago
- Stocks Supported by Strength in ChipmakersBarchart · 6 days ago
- Stocks Rebound as Crude Oil Prices Fall and Chipmakers RecoverBarchart · 6 days ago
- Waters Q3 Earnings & Revenues Beat Estimates, 2026 Guidance RaisedZacks · 6 days ago
- Waters Corporation Reports Third Quarter 2026 Financial ResultsFintel · 6 days ago
- Waters (WAT) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks · 6 days ago
- Waters Acquires MOBILion Systems To Expand Proteomics Business RTTNews · 6 days ago
The company
Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~15,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide.
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NYSE
- Region
- North America
- Website
- waters.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.